Erick Lucera - 03 Apr 2023 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Erick Lucera
Issuer symbol
SABS
Transactions as of
03 Apr 2023
Transactions value $
$0
Form type
3
Filing time
05 Apr 2023, 17:00:38
Previous filing
31 Mar 2023
Next filing
18 May 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.